how was glp-1 discovered Discovery of GLP-1–Based Drugs for the Treatment of Obesity JCI - The GLP-1 journey:

A person shouldnt take Wegovy if they: Have a personal or family history of medullary thyroid carcinoma (MTC) or multiple endocrine neoplasia syndrome type 2 (MEN 2)

Cold foods have less smell

The most common complaints are nausea, constipation, headache, insomnia, and a bump in blood pressure and heart rate and nausea is actually the top reason people stop taking it

November 13, 2024

Do at least two strength-building sessions each week that exercise all major muscle groups in your body

Both the semaglutide and tirzepatide shortages that made compounding legally available were declared resolved in 2024 and 2025, the compounding wind-down deadlines have passed, and in April 2026 the FDA proposed closing the remaining legal pathway entirely